Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
17%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_3
1
14%
Ph phase_1
6
86%

Phase Distribution

6

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
6(85.7%)
Phase 3Large-scale testing
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(6)
Terminated(1)

Detailed Status

Completed6
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (85.7%)
Phase 31 (14.3%)

Trials by Status

completed686%
terminated114%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_1

Safety, Tolerability, and Pharmacokinetics of KBP-5074 Following Oral Administration in Chronic Kidney Disease

NCT02837237
completedphase_1

Mass Balance Study of KBP-5074 in Healthy Male Subjects

NCT04634812
completedphase_1

Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment

NCT02653014
completedphase_1

Phase 1 Single Ascending Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of KBP-5074

NCT02228733
completedphase_1

Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects

NCT04606537
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT02837237Phase 1

Safety, Tolerability, and Pharmacokinetics of KBP-5074 Following Oral Administration in Chronic Kidney Disease

Completed
NCT04634812Phase 1

Mass Balance Study of KBP-5074 in Healthy Male Subjects

Completed
NCT02653014Phase 1

Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment

Completed
NCT02228733Phase 1

Phase 1 Single Ascending Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of KBP-5074

Completed
NCT04606537Phase 1

Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects

Completed
NCT04534699Phase 1

Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment

Completed
NCT04968184Phase 3

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

Terminated

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7